Erythromelalgia successfully treated with low-dose gabapentin in a pediatric patient

Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition. Herein, we report a 7-year-old girl who experienced resolution of erythromela...

Descripción completa

Detalles Bibliográficos
Autores principales: Phong, Celine H, Birmingham, Suzanne W, Rojek, Nathan W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666850/
https://www.ncbi.nlm.nih.gov/pubmed/36406307
http://dx.doi.org/10.1177/2050313X221136768
Descripción
Sumario:Primary erythromelalgia, while uncommon, may significantly decrease the quality of life of those affected. While many patients with erythromelalgia require systemic therapy, there is no standard of care for this condition. Herein, we report a 7-year-old girl who experienced resolution of erythromelalgia symptoms with no adverse effects after treatment with low-dose gabapentin. We also discuss the safety and efficacy of low-dose gabapentin in children for treatment of pain.

Ejemplares similares